Evidence map›Paper›PMID 40696688›Full record

ReviewMedicine2025

Atypical presentation of secondary hepatic lymphoma with severe hepatic involvement: A case report and literature review.

Dongliang Zhao, Lai Wei, Lihong Li, Yanying Wang

Abstract readCase ReportsReview
In one paragraph

Review in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dongliang ZhaoSchool of Clinical Medicine, Tsinghua University, Beijing, China.ORCID 0009-0008-6142-4698
Lai WeiSchool of Clinical Medicine, Tsinghua University, Beijing, China.
Lihong LiDepartment of Hematology Oncology, Beijing Tsinghua Changgung Hospital, Beijing, China.
Yanying WangDepartment of Hematology Oncology, Beijing Tsinghua Changgung Hospital, Beijing, China.ORCID 0009-0000-1056-8650

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleWhile secondary hepatic lymphoma can develop in up to 50% of patients with non-Hodgkin lymphoma and approximately 20% of those with Hodgkin disease, it is uncommon for patients to present with severe hepatic involvement, manifesting initially as jaundice and abdominal pain. These nonspecific symptoms can complicate diagnosis and subsequently delay the initiation of appropriate treatment. PATIENT CONCERNS: A 68-year-old female presented to our hospital with complaints of abdominal pain and jaundice. DIAGNOSES: Laboratory tests and clinical symptoms are often nonspecific for this atypical presentation of secondary hepatic lymphoma, and imaging findings can be challenging to distinguish. Histopathological examination remains the gold standard for diagnosis.

interventionsDue to severe thrombocytopenia and coagulopathy, only low-dose prephase chemotherapy was administered along with supportive treatments, including platelet transfusion and coagulation factor supplementation. OUTCOMES: The patient was dead. No autopsy was performed, as the patient's family declined consent. LESSONS: Clinicians should maintain high vigilance for atypical presentations of lymphoma, especially when encountering unexplained cholestatic hepatitis and cytopenias, and promptly initiate diagnostic evaluations to avoid delays in treatment. A definitive diagnosis primarily relies on histopathological examination, with chemotherapy remaining the cornerstone of treatment.

Indexed as

Liver NeoplasmsLymphomaLymphoma, Non-HodgkinAbdominal PainAgedFatal OutcomeFemaleHumansJaundicediffuse large B-cell lymphomajaundice and abdominal painsecondary hepatic lymphoma

Identifiers

PMID40696688
PMCPMC12282755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.